SCNI (Scinai Immunotherapeutics Ltd.) Book Value per Share
Equity per share reflects the trajectory of Scinai Immunotherapeutics (SCNI) as it undergoes intensive R&D to create innovative nanobodies. The value 10.69 is recorded as the baseline value. Revenue is projected to be generated through the implementation of treatments against influenza, COVID-19, and dermatitis. However, fierce competition for government grants and pressure from vaccination behemoths create significant risks for scaling the business.
Summary analytical data breakdowns for scinai.com (SCNI)
- current quotes and average value forecast:
- business market valuation indicators:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Scinai Immunotherapeutics|SCNI - Long-Term Debt to Capital|Short-Term Debt to Equity Scinai Immunotherapeutics Ltd.|SCNI - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Scinai Immunotherapeutics Ltd.|SCNI - Company Long-Term Liabilities|Company Short-Term Debts Scinai Immunotherapeutics|Quick Liquidity Indicator scinai.com
- earnings and multiples data:
General company analysis:SCNI - Scinai
Amidst a fierce scientific race in biopharmaceuticals, Scinai Immunotherapeutics (SCNI) relies on efficient capital management to compete with global leaders. The dynamics of the net book value per share reflect the remaining assets after all liabilities are settled, demonstrating the business's real financial resilience. Growth in this indicator confirms a strengthening fundamental base, whereas stagnation may signal an inefficient use of resources.
Competitor analysis
ARGX - Net Assets per Single Share|BNTX (BioNTech Pharma) - Equity per Share|ABVX: Book Value per Share|ADMA - Net Assets per Share|Net Assets per Single Share Protagonist|Immunovant Inc - Share Book Value|Book Value per Share KNSA|GRFS (Grifols Biemat) - Accounting Value of a Share|Book Value per Share ADPT (Adaptive Biotechnologies)|Book Value per Share celldex.com CLDX|AUPH - Net Assets per Single Share|Accounting Value of a Share BCRX (BioCryst Pharmaceuticals, Inc.)|Vera Pharma (VERA) - Net Assets per Single Share|Accounting Value per Share Dianthus Corp|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp|Accounting Value per Share TRML (Tourmaline Bio)|PGEN (Precigen Inc) - Accounting Value of a Share|Book Value per Share PHAR (Pharming)|Net Assets per Share Nektar Corp (NKTR)|UPB - Net Assets per Single Share|zenasbio.com (ZBIO) - Accounting Value per Share|Immunome (IMNM) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|Accounting Value per Share KALV|Book Value per Share Septerna Pharma|Net Assets per Single Share Pieris Pharmaceuticals (PVLA)|savarapharma.com - Equity per Share|Book Value per Share RIGL (Rigel Pharmaceuticals, Inc.)|AnaptysBio Inc (ANAB) - Net Asset Value per Share|ATXS - Net Assets per Single Share|Net Assets per Share enGene Corp ENGN|RAPT: Book Value per Share|Accounting Value per Share Aerovate Therapeutics|ACRS (Aclaris Therapeutics, Inc.) - Book Value per Share|Kyverna Therapeutics Inc. (KYTX) - Net Assets per Share|Net Assets per Single Share Tiziana Life Sciences PLC (TLSA)|Cabaletta Bio Inc - Equity per Share|Book Value per Share VTYX (Ventyx Biosciences)|Book Value per Share theratech.com THTX|Avalo Therapeutics - Book Value per Share|Net Assets per Share Eledon Pharmaceuticals Inc. ELDN|AGEN (Agenus Inc) - Accounting Value per Share|Climb Bio, Inc - Accounting Value of a Share|ZURA (Zura Bio Limited) - Book Value per Share|atyrpharma.com (ATYR) - Net Assets per Share|Net Assets per Single Share Adagene (ADAG)|Accounting Value per Share ikenaoncology.com IMA|Net Assets per Single Share Shattuck Labs STTK|EQ - Accounting Value per Share|CNTB: Accounting Value per Share|IMUX - Book Value per Share|atarabio.com (ATRA) - Net Assets per Single Share|Equity per Share IFRX|Net Assets per Single Share X4 Pharma|Net Asset Value per Share Adicet ACET|Accounting Value per Share CELU (Celularity Inc.)|Book Price of a Share INMB|Book Value per Share BRNS (Barinthus Biotherapeutics plc)|Accounting Value of a Share KZR|SAB Biotherapeutics, Inc - Book Value per Share|Net Asset Value per Share Akari Therapeutics, Plc|enlivex.com (ENLV) - Net Assets per Single Share|Q32 Bio - Accounting Value of a Share|GOVX (GeoVax) - Book Value per Share|Book Value per Share Edesa Biotech Inc|Net Assets per Single Share iBio Corp (IBIO)|CARM: Share Book Value|Book Value per Share XTLB (XTL Biopharmaceuticals)|Bolt Biotherapeutics Inc. (BOLT) - Net Asset Value per Share|HCWB: Accounting Value per Share|APVO - Book Value per Share|AIM (AIM ImmunoTech) - Accounting Value per Share|ADTX: Book Price of a Share|GRI (GRI Bio, Inc.) - Book Value per Share|xortx.com (XRTX) - Net Assets per Share|Book Value per Share HIND|Accounting Value per Share Revelation Biosciences Inc REVB|Net Assets per Single Share Indaptus INDP|Net Assets per Share CalciMedica Inc (CALI)|AFMD - Net Assets per Single Share|Net Assets per Share Allakos Inc. ALLK|HOOK: Book Value per Share|Accounting Value per Share IGM Biosciences|Net Assets per Single Share iTeos|Equity per Share OCEA (Ocean Biomedical Corp)|Book Value per Share TCBP|Net Assets per Share thirdharmonicbio.com